However, a study of the CTCF mRNA level in breast carcinoma revealed no significant tumor-associated loss or decrease in expression, and therefore CTCF is unlikely to be a tumor suppressor gene targeted by the 16q22.1 loss in breast cancer [30]. This evidence concerns the gene CTCF and breast carcinoma.